CYTOF Financial Statements

Balance sheet, income statement, cash flow, and dividends for Altamira Therapeutics Ltd (CYTOF).


CHF1.38M Market Cap.

As of 04/10/2024 5:00 PM ET (MRY) • Disclaimer

CYTOF Market Cap. (MRY)


CYTOF Shares Outstanding (MRY)


CYTOF Assets (MRY)


Total Assets

CHF7.69M

Total Liabilities

CHF1.24M

Total Investments

CHF2.42M

CYTOF Income (MRY)


Revenue

CHF0

Net Income

-CHF3.87M

Operating Expense

CHF5.92M

CYTOF Cash Flow (MRY)


CF Operations

-CHF11.51M

CF Investing

CHF1.44M

CF Financing

CHF10.62M

CYTOF Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

0%

0%

-

2019

$0

0%

-

0%

-

CYTOF Balance Sheet (MRY)


Metric

2023

2022

2021

2020

Total Assets

CHF7,694,259 (22.08%)

CHF6,302,765 (-67.12%)

CHF19,170,321 (-7.83%)

CHF20,799,367 (125.44%)

Assets Current

CHF1,223,154 (-30.86%)

CHF1,768,993 (-56.77%)

CHF4,091,624 (-64.78%)

CHF11,617,320 (389.38%)

Assets Non-Current

CHF6,471,105 (42.73%)

CHF4,533,772 (-69.93%)

CHF15,078,697 (64.22%)

CHF9,182,047 (34.00%)

Goodwill & Intangible Assets

CHF3,893,681 (0.00%)

CHF3,893,681 (-72.80%)

CHF14,314,877 (57.04%)

CHF9,115,410 (34.73%)

Shareholders Equity

CHF6,458,717 (177.68%)

-CHF8,314,811 (-163.78%)

CHF13,036,251 (-22.26%)

CHF16,769,890 (177.83%)

Property Plant & Equipment Net

CHF80,111 (-82.03%)

CHF445,828 (-21.05%)

CHF564,715 (1110.90%)

CHF46,636 (-30.05%)

Cash & Equivalents

CHF617,409 (3910.45%)

CHF15,395 (-98.44%)

CHF984,191 (-91.26%)

CHF11,258,870 (713.08%)

Accumulated Other Comprehensive Income

CHF0 (0%)

CHF0 (0%)

CHF62,069 (1.26%)

CHF61,297 (322.37%)

Deferred Revenue

CHF0 (0%)

CHF932,200 (0%)

CHF0 (0%)

CHF0 (0%)

Total Investments

CHF2,417,312 (0%)

CHF0 (0%)

CHF0 (0%)

CHF0 (0%)

Investments Current

CHF0 (0%)

CHF0 (0%)

CHF0 (0%)

CHF0 (0%)

Investments Non-Current

CHF2,417,312 (0%)

CHF0 (0%)

CHF0 (0%)

CHF0 (0%)

Inventory

CHF0 (0%)

CHF11,644 (-98.61%)

CHF839,221 (0%)

CHF0 (0%)

Trade & Non-Trade Receivables

CHF74,823 (-90.19%)

CHF762,512 (10.02%)

CHF693,086 (757.13%)

CHF80,861 (-77.24%)

Trade & Non-Trade Payables

CHF440,414 (-91.04%)

CHF4,914,404 (32.90%)

CHF3,697,723 (384.98%)

CHF762,453 (-18.74%)

Accumulated Retained Earnings (Deficit)

-CHF18,046,002 (91.04%)

-CHF201,431,272 (-14.65%)

-CHF175,686,937 (-9.37%)

-CHF160,635,879 (-5.14%)

Tax Assets

CHF0 (0%)

CHF0 (0%)

CHF0 (0%)

CHF0 (0%)

Tax Liabilities

CHF0 (0%)

CHF125,870 (-11.66%)

CHF142,484 (13.20%)

CHF125,865 (-14.46%)

Total Debt

CHF99,659 (-98.43%)

CHF6,331,282 (999.68%)

CHF575,736 (9.89%)

CHF523,920 (0%)

Debt Current

CHF99,659 (-98.34%)

CHF5,987,653 (5140.79%)

CHF114,251 (-78.19%)

CHF523,920 (0%)

Debt Non-Current

CHF0 (0%)

CHF343,629 (-25.54%)

CHF461,485 (0%)

CHF0 (0%)

Total Liabilities

CHF1,235,542 (-91.55%)

CHF14,617,576 (138.30%)

CHF6,134,070 (52.23%)

CHF4,029,477 (26.32%)

Liabilities Current

CHF888,914 (-93.10%)

CHF12,879,671 (164.98%)

CHF4,860,549 (60.42%)

CHF3,029,918 (33.00%)

Liabilities Non-Current

CHF346,628 (-80.05%)

CHF1,737,905 (36.46%)

CHF1,273,521 (27.41%)

CHF999,559 (9.61%)

CYTOF Income Statement (MRY)


Metric

2023

2022

2021

2020

Revenues

CHF0 (0%)

CHF305,616 (378.41%)

CHF63,882 (0%)

CHF0 (0%)

Cost of Revenue

CHF0 (0%)

CHF1,443,855 (-35.56%)

CHF2,240,554 (0%)

CHF0 (0%)

Selling General & Administrative Expense

CHF3,136,275 (-47.95%)

CHF6,025,933 (-6.50%)

CHF6,444,794 (148.39%)

CHF2,594,662 (-34.04%)

Research & Development Expense

CHF3,035,413 (-84.57%)

CHF19,677,756 (135.36%)

CHF8,360,821 (192.03%)

CHF2,862,979 (-13.90%)

Operating Expenses

CHF5,916,099 (-76.33%)

CHF24,995,377 (71.30%)

CHF14,591,398 (165.16%)

CHF5,502,781 (-24.20%)

Interest Expense

CHF1,668,475 (82.97%)

CHF911,869 (380.70%)

CHF189,695 (40.36%)

CHF135,151 (372.09%)

Income Tax Expense

CHF0 (0%)

-CHF10,329 (-147.78%)

CHF21,620 (201.58%)

-CHF21,284 (89.02%)

Net Loss Income from Discontinued Operations

-CHF3,400,865 (0%)

CHF0 (0%)

CHF0 (0%)

CHF0 (0%)

Consolidated Income

-CHF3,869,173 (85.41%)

-CHF26,528,411 (-55.51%)

-CHF17,058,443 (-108.03%)

-CHF8,200,165 (-23.65%)

Net Income to Non-Controlling Interests

CHF0 (0%)

CHF0 (0%)

CHF0 (0%)

CHF0 (0%)

Net Income

-CHF3,869,173 (85.41%)

-CHF26,528,411 (-55.51%)

-CHF17,058,443 (-108.03%)

-CHF8,200,165 (-23.65%)

Preferred Dividends Income Statement Impact

CHF0 (0%)

CHF0 (0%)

CHF0 (0%)

CHF0 (0%)

Net Income Common Stock

-CHF3,869,173 (85.41%)

-CHF26,528,411 (-55.51%)

-CHF17,058,443 (-108.03%)

-CHF8,200,165 (-23.65%)

Weighted Average Shares

CHF397,700 (-53.39%)

CHF853,213 (25.08%)

CHF682,156 (169.68%)

CHF252,954 (169.85%)

Weighted Average Shares Diluted

-

-

-

-

Earning Before Interest & Taxes (EBIT)

-CHF2,200,698 (91.41%)

-CHF25,626,871 (-52.11%)

-CHF16,847,128 (-108.34%)

-CHF8,086,298 (-18.97%)

Gross Profit

CHF0 (0%)

-CHF1,138,239 (47.71%)

-CHF2,176,672 (0%)

CHF0 (0%)

Operating Income

-CHF5,916,099 (77.36%)

-CHF26,133,616 (-55.85%)

-CHF16,768,070 (-204.72%)

-CHF5,502,781 (24.20%)

CYTOF Cash Flow Statement (MRY)


Metric

2023

2022

2021

2020

Net Cash Flow from Investing

CHF1,444,869 (167.46%)

-CHF2,141,837 (38.89%)

-CHF3,505,056 (-51.41%)

-CHF2,314,974 (22.85%)

Net Cash Flow from Financing

CHF10,621,615 (8.03%)

CHF9,831,995 (48.66%)

CHF6,613,724 (-61.01%)

CHF16,961,069 (129.89%)

Net Cash Flow from Operations

-CHF11,511,064 (-32.57%)

-CHF8,683,231 (36.49%)

-CHF13,672,738 (-182.29%)

-CHF4,843,470 (42.29%)

Net Cash Flow / Change in Cash & Cash Equivalents

CHF555,420 (155.93%)

-CHF993,073 (90.60%)

-CHF10,564,070 (-207.77%)

CHF9,802,625 (344.08%)

Net Cash Flow - Business Acquisitions and Disposals

CHF1,434,324 (0%)

CHF0 (0%)

CHF0 (0%)

CHF0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

CHF10,040 (0%)

CHF0 (0%)

-CHF179,104 (0%)

CHF0 (0%)

Capital Expenditure

CHF0 (0%)

CHF0 (0%)

CHF0 (0%)

CHF0 (0%)

Issuance (Repayment) of Debt Securities

CHF1,049,025 (-82.29%)

CHF5,924,376 (8723.55%)

-CHF68,700 (-104.51%)

CHF1,522,931 (204.07%)

Issuance (Purchase) of Equity Shares

CHF10,507,223 (165.16%)

CHF3,962,618 (-42.09%)

CHF6,842,940 (-57.43%)

CHF16,074,996 (64.14%)

Payment of Dividends & Other Cash Distributions

CHF0 (0%)

CHF0 (0%)

CHF0 (0%)

CHF0 (0%)

Effect of Exchange Rate Changes on Cash

CHF46,594 (91.93%)

CHF24,277 (-91.61%)

CHF289,391 (304.60%)

CHF71,525 (823.62%)

Share Based Compensation

CHF379,414 (10.68%)

CHF342,799 (-71.58%)

CHF1,206,303 (227.09%)

CHF368,793 (62.75%)

Depreciation Amortization & Accretion

CHF119,304 (0.35%)

CHF118,887 (55.70%)

CHF76,357 (281.10%)

CHF20,036 (-35.00%)

CYTOF Financial Metrics (MRY)


Metric

2023

2022

2021

2020

Gross Margin

-

-372.40% (89.07%)

-3407.30%

-

Profit Margin

-

-8680.30% (67.49%)

-26703.10%

-

EBITDA Margin

-

-8346.40% (68.21%)

-26252.70%

-

Return on Average Equity (ROAE)

416.90% (137.10%)

-1123.70% (-881.40%)

-114.50% (-59.25%)

-71.90% (47.48%)

Return on Average Assets (ROAA)

-55.30% (73.45%)

-208.30% (-143.91%)

-85.40% (-56.41%)

-54.60% (21.33%)

Return on Sales (ROS)

-

-8385.30% (68.20%)

-26372.30%

-

Return on Invested Capital (ROIC)

250.00% (-77.72%)

1122.00% (-16.94%)

1350.80% (174.22%)

492.60% (22.51%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-0.37 (-139.35%)

-0.15 (87.91%)

-1.28 (29.75%)

-1.82 (86.76%)

Price to Sales Ratio (P/S)

-

12.59 (-96.43%)

352.74

-

Price to Book Ratio (P/B)

0.18 (138.88%)

-0.46 (-126.78%)

1.73 (148.42%)

0.7 (42.62%)

Debt to Equity Ratio (D/E)

0.19 (110.86%)

-1.76 (-473.25%)

0.47 (96.25%)

0.24 (-54.55%)

Earnings Per Share (EPS)

-7.88 (72.95%)

-29.13 (-13.08%)

-25.76 (-1.94%)

-25.27 (-1008.33%)

Sales Per Share (SPS)

0 (0%)

0.39 (273.79%)

0.1 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-28.94 (-184.41%)

-10.18 (49.22%)

-20.04 (-4.67%)

-19.15 (78.78%)

Book Value Per Share (BVPS)

16.24 (266.65%)

-9.74 (-150.99%)

19.11 (-71.17%)

66.3 (2.96%)

Tangible Assets Book Value Per Share (TABVPS)

9.56 (238.39%)

2.82 (-60.33%)

7.12 (-84.59%)

46.19 (75.97%)

Enterprise Value Over EBIT (EV/EBIT)

-2 (0%)

0 (0%)

-1 (0.00%)

-1 (0%)

Enterprise Value Over EBITDA (EV/EBITDA)

-2.11 (-525.52%)

-0.34 (60.07%)

-0.84 (41.67%)

-1.45 (-454.66%)

Asset Turnover

0 (0%)

0.02 (700.00%)

0 (0%)

0 (0%)

Current Ratio

1.38 (904.38%)

0.14 (-83.73%)

0.84 (-78.04%)

3.83 (267.95%)

Dividends

CHF0 (0%)

CHF0 (0%)

CHF0 (0%)

CHF0 (0%)

Free Cash Flow (FCF)

-CHF11,511,064 (-32.57%)

-CHF8,683,231 (36.49%)

-CHF13,672,738 (-182.29%)

-CHF4,843,470 (42.73%)

Enterprise Value (EV)

CHF5,223,737 (-43.48%)

CHF9,241,571 (-40.60%)

CHF15,559,022 (17.29%)

CHF13,265,736 (566.62%)

Earnings Before Tax (EBT)

-CHF3,869,173 (85.42%)

-CHF26,538,740 (-55.77%)

-CHF17,036,823 (-107.22%)

-CHF8,221,449 (-20.45%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-CHF2,081,394 (91.84%)

-CHF25,507,984 (-52.10%)

-CHF16,770,771 (-107.91%)

-CHF8,066,262 (-19.21%)

Invested Capital

CHF2,393,914 (157.62%)

-CHF4,154,700 (-904.62%)

-CHF413,560 (80.13%)

-CHF2,080,911 (-73.08%)

Working Capital

CHF334,240 (103.01%)

-CHF11,110,678 (-1344.96%)

-CHF768,925 (-108.95%)

CHF8,587,402 (8864.26%)

Tangible Asset Value

CHF3,800,578 (57.76%)

CHF2,409,084 (-50.38%)

CHF4,855,444 (-58.44%)

CHF11,683,957 (374.85%)

Market Capitalization

CHF1,383,997 (-66.55%)

CHF4,138,083 (-83.29%)

CHF24,762,281 (86.82%)

CHF13,254,800 (336.42%)

Average Equity

-CHF928,047 (-139.31%)

CHF2,360,720 (-84.16%)

CHF14,903,070 (30.69%)

CHF11,403,012 (135.46%)

Average Assets

CHF6,998,512 (-45.05%)

CHF12,736,543 (-36.27%)

CHF19,984,844 (33.12%)

CHF15,012,759 (57.18%)

Invested Capital Average

-CHF880,393 (61.46%)

-CHF2,284,130 (-83.14%)

-CHF1,247,236 (24.02%)

-CHF1,641,581 (2.90%)

Shares

397,700 (-53.39%)

853,213 (25.08%)

682,156 (169.68%)

252,954 (169.85%)